Category Health & IP

El informe anual del USTR sobre propiedad intelectual da prioridad a la observancia

Por William New El informe anual del Gobierno de Estados Unidos que evalúa la protección de los derechos de propiedad intelectual estadounidenses en los socios comerciales extranjeros y que, posiblemente, desalienta la inversión en países errantes se centró este año,…

Débat sur les politiques en matière de cartographie des brevets appliqués aux sciences de la vie

Kaitlin Mara Il est aussi important que compliqué d’avoir accès à des données de qualité sur les politiques menées en matière de propriété intellectuelle appliquée aux sciences de la vie. Telle est la conclusion d’une récente réunion d’experts techniques relative…

Los expertos examinan la reglamentación de los estudios de situación de las patentes para las biociencias

Por Kaitlin Mara Tener acceso a datos de calidad en el contexto de la reglamentación de la propiedad intelectual en el ámbito de las biociencias es una cuestión tan necesaria como difícil, según se dijo en una reunión de expertos…

Rise Of Enforcement Priorities Reflected In Annual USTR IP Report

By William New The annual United States government report aimed at boosting global protection of US intellectual property rights and discouraging investment in errant nations this year again took sharpest aim at China and Russia, but also raised the alert…

Brazil Declares Patented AIDS Drug Of Public Interest, Could Expand Access

By Claudia Jurberg for Intellectual Property Watch The Brazilian government recently declared the drug Tenofovir, used against HIV/AIDS, to be of public interest. The announcement signals the country’s interest in using an option to avoid the patent on the drug…

Experts Discuss Policy On Patent Landscapes For Life Sciences

By Kaitlin Mara Access to quality data in intellectual property policy in the life sciences is as necessary as it is hard to obtain, said a recent meeting of technical experts, called to discuss challenges in patents and innovation in…

Innovative Partnership To Create Another Patent-Free Malaria Drug

By Catherine Saez After an innovative partnership between a non-governmental group and a pharmaceutical company led to a new cheap non-patented drug against malaria being available in Africa in 2007, the model is being implemented again with another new non-patented…

EPO Head Sees Need To Review IP Rules For Climate Change

By David Cronin for Intellectual Property Watch
BRUSSELS - Changes to intellectual property rules may be needed to facilitate the use of technology aimed at addressing climate change, the head of the European Patent Office (EPO) has suggested.

Next month, the 34-country EPO will host what it claims is the first major international conference to examine the patenting issues raised by global warming.

Alison Brimelow, the EPO's president, said the European Patent Forum in the Slovenian capital Ljubljana will give an opportunity to exchange ideas on whether the international system for regulating intellectual property should be modified.